CTRI/2009/091/000896已完成3 期
An Open Label, Randomized, Parallel Group, Prospective, Multicentre Clinical Trial for Evaluation of Efficacy and Safety of Fixed Dose Combination of Minoxidil (5%) + Finasteride (0.1%) Lipid Solution in Comparison with Minoxidil (5%) Solution in Adult Male Patients with Androgenic Alopecia
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Inclusion Criteria:
- •(1) Male 18 to 45 years of age, with androgenic alopecia with II to V grade on the modified Norwood Hamilton classification
- •(2) Willingness to maintain the same hair style, approximate length, and hair color throughout the study
- •(3) Subjects willing to provide written informed consent
排除标准
- •(1) Concomitant dermatological disorders on the scalp
- •(2) Serious cardiovascular diseases, renal diseases or hepatic diseases
- •(3) History of drug hypersensitivity, breast disorders or testicular disorders
- •(4) Wearing a wig or under gone surgical treatment for hair loss
- •(5) Shaved scalp or undergoing topical scalp treatment
- •(6) Clinically significant abnormalities on physical examination or laboratory tests
- •(7) History of medication interfering with the study objectives
- •(8) Ongoing use of prohibited medications
研究者
相似试验
已完成
3 期
Phase III clinical trial for Evaluation of Efficacy and Safety of IN-ALRN-001 in Comparison with Tamsulosin in Patients with lower urinary tract symptoms associated with BPH.CTRI/2009/091/000742Intas Pharmaceuticals Limited200
已完成
3 期
A clinical trial to study the effects of two drugs, IN-ASTR-001 and fluoxetine in patients with major depression.CTRI/2011/05/001719Intas Pharmaceuticals Limited280
暂停
3 期
A phase 3 clinical trial to study the efficacy and safety of drug fasudil in comparison with nimodipine in patients with non-traumatic subarachnoid hemorrhageCTRI/2010/091/000422Intas Pharmaceuticals Limited200
进行中（未招募）
4 期
Clinical study toevaluate the effect of flavoured oats and blended oil with antioxidants in preâ??diabetes subjectsCTRI/2015/12/006429Spectrum Clinical Research Pvt Ltd
进行中（未招募）
不适用
A Randomized, Open Label, Parallel Group, International, Multicenter, Phase III Study of Oral ZD1839 (IRESSA®) Versus Intravenous Docetaxel (TAXOTERE®) in Patients With Locally Advanced or Metastatic Recurrent Non Small Cell Lung Cancer who have Previously Received Platinum Based Chemotherapy - INTERESTocally Advanced or Metastatic Recurrent Non-Small Cell Lung CancerEUCTR2004-002943-28-LVAstraZeneca AB1,440